Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

Shaelyn Weaver, after struggling with weight issues due to PCOS and pre-diabetes, embarked on a significant weight loss ...

Weight loss jabs How it works ... How effective it is: Trials pivotal to getting Novo Nordisk's semaglutide approved show it can help users shed up to 15 per cent of their body weight ...

The mother-of-three hit back at eldest child Violet, 14, after the teenager convinced herself that her mother was on Ozempic.

Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:NVO) ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

The promise of quick and easy weight loss has made fat burners a multi-billion dollar industry, but mounting evidence suggests these supplements might be doing more harm than good. As more people ...